Patient Name: Harber290, Sam879, Gender: male, Birth Date: 1962-04-21 Condition: Serving in military service (finding), Onset: 1980-06-14T18:35:13+00:00 Condition: Received higher education (finding), Onset: 1980-06-14T18:35:13+00:00 Medication: Hydrocortisone 10 MG/ML Topical Cream, Dosage: Take as needed. Medication: Fexofenadine hydrochloride 60 MG Oral Tablet, Dosage: Take as needed. Medication: NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector, Dosage: Take as needed. Condition: Seizure disorder (disorder), Onset: 2011-06-04T17:44:47+00:00 Condition: History of seizure (situation), Onset: 2011-06-04T17:44:47+00:00 Condition: Epilepsy (disorder), Onset: 2011-06-04T20:35:25+00:00 Condition: Full-time employment (finding), Onset: 2012-04-21T18:21:52+00:00 Condition: Stress (finding), Onset: 2012-04-21T18:21:52+00:00 Medication: Diazepam 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Atrial fibrillation (disorder), Onset: 2013-04-27T17:44:47+00:00 Condition: Misuses drugs (finding), Onset: 2014-05-03T19:39:11+00:00 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Medication review due (situation), Onset: 2015-05-09T17:44:47+00:00 Condition: Gingivitis (disorder), Onset: 2015-05-09T19:04:49+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 1 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 79 Observation: Respiratory rate, Value: 14 Observation: Cholesterol [Mass/volume] in Serum or Plasma, Value: 120.79 Observation: Triglycerides, Value: 115.8 Observation: Low Density Lipoprotein Cholesterol, Value: 40.21 Observation: Cholesterol in HDL [Mass/volume] in Serum or Plasma, Value: 57.42 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Total score [AUDIT-C], Value: 2 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Leaking dental filling (finding), Onset: 2015-05-23T20:57:09+00:00 Condition: Medication review due (situation), Onset: 2016-05-14T17:44:47+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 4 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 99 Observation: Respiratory rate, Value: 14 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ], Value: 0 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 1 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 2 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 81 Observation: Respiratory rate, Value: 15 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Total score [HARK], Value: 0 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 4 Observation: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported], Value: 6 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Part-time employment (finding), Onset: 2018-05-26T18:24:46+00:00 Condition: Stress (finding), Onset: 2018-05-26T18:24:46+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 2 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 77 Observation: Respiratory rate, Value: 15 Observation: Cholesterol [Mass/volume] in Serum or Plasma, Value: 180.65 Observation: Triglycerides, Value: 111.65 Observation: Low Density Lipoprotein Cholesterol, Value: 100.01 Observation: Cholesterol in HDL [Mass/volume] in Serum or Plasma, Value: 58.31 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ], Value: 2 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 0 Observation: Total score [AUDIT-C], Value: 2 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Sprain (morphologic abnormality), Onset: 2018-11-21T17:44:47+00:00 Condition: Sprain of ankle (disorder), Onset: 2018-11-21T17:44:47+00:00 Medication: Naproxen sodium 220 MG Oral Tablet, Dosage: Take as needed. Condition: Medication review due (situation), Onset: 2019-06-01T17:44:47+00:00 Condition: Full-time employment (finding), Onset: 2019-06-01T18:23:20+00:00 Condition: Social isolation (finding), Onset: 2019-06-01T18:23:20+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 0 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 75 Observation: Respiratory rate, Value: 15 Observation: Leukocytes [#/volume] in Blood by Automated count, Value: 5.6492 Observation: Erythrocytes [#/volume] in Blood by Automated count, Value: 5.1318 Observation: Hemoglobin [Mass/volume] in Blood, Value: 14.02 Observation: Hematocrit [Volume Fraction] of Blood by Automated count, Value: 38.817 Observation: MCV [Entitic volume] by Automated count, Value: 88.32 Observation: MCH [Entitic mass] by Automated count, Value: 28.282 Observation: MCHC [Mass/volume] by Automated count, Value: 35.176 Observation: Erythrocyte distribution width [Entitic volume] by Automated count, Value: 43.865 Observation: Platelets [#/volume] in Blood by Automated count, Value: 188.21 Observation: Platelet distribution width [Entitic volume] in Blood by Automated count, Value: 311.14 Observation: Platelet mean volume [Entitic volume] in Blood by Automated count, Value: 10.843 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Total score [HARK], Value: 0 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 1 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Dental filling lost (finding), Onset: 2019-06-15T20:26:37+00:00 Condition: Viral sinusitis (disorder), Onset: 2019-12-21T04:44:47+00:00 Condition: Medication review due (situation), Onset: 2020-06-06T17:44:47+00:00 Condition: Part-time employment (finding), Onset: 2020-06-06T18:21:50+00:00 Condition: Gingivitis (disorder), Onset: 2020-06-06T19:16:57+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 2 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 64 Observation: Respiratory rate, Value: 15 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ], Value: 1 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 2 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Medication: Unknown medication, Dosage: Unknown dosage Condition: Stress (finding), Onset: 2021-06-12T18:25:33+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 1 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 99 Observation: Respiratory rate, Value: 13 Observation: Cholesterol [Mass/volume] in Serum or Plasma, Value: 159.56 Observation: Triglycerides, Value: 133.56 Observation: Low Density Lipoprotein Cholesterol, Value: 69.18 Observation: Cholesterol in HDL [Mass/volume] in Serum or Plasma, Value: 63.67 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 1 Observation: Total score [DAST-10], Value: 2 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Full-time employment (finding), Onset: 2021-07-24T18:41:32+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 1 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 70 Observation: Respiratory rate, Value: 14 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 1 Observation: Total score [DAST-10], Value: 0 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Acute bronchitis (disorder), Onset: 2021-07-31T17:44:47+00:00 Medication: Acetaminophen 325 MG Oral Tablet, Dosage: Unknown dosage Condition: Medication review due (situation), Onset: 2022-06-18T17:44:47+00:00 Condition: Stress (finding), Onset: 2022-06-18T18:35:33+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 3 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 95 Observation: Respiratory rate, Value: 15 Observation: Tobacco smoking status, Value: Unknown value Observation: Physical findings of Prostate, Value: Unknown value Observation: Prostate specific Ag [Mass/volume] in Serum or Plasma, Value: 2.3262 Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ], Value: 0 Observation: Total score [HARK], Value: 0 Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 5 Observation: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported], Value: 19 Observation: Total score [AUDIT-C], Value: 1 Observation: Physical findings of Prostate, Value: Unknown value Observation: Prostate specific Ag [Mass/volume] in Serum or Plasma, Value: 1.7562 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Part-time employment (finding), Onset: 2023-06-24T18:41:08+00:00 Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 1 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 65 Observation: Respiratory rate, Value: 14 Observation: Tobacco smoking status, Value: Unknown value Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported], Value: 2 Observation: Total score [AUDIT-C], Value: 1 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Observation: Body Height, Value: 175.8 Observation: Pain severity - 0-10 verbal numeric rating [Score] - Reported, Value: 2 Observation: Body Weight, Value: 85.4 Observation: Body mass index (BMI) [Ratio], Value: 27.63 Observation: Blood pressure panel with all children optional, Value: Unknown value Observation: Heart rate, Value: 61 Observation: Respiratory rate, Value: 13 Observation: Cholesterol [Mass/volume] in Serum or Plasma, Value: 221.75 Observation: Triglycerides, Value: 113.36 Observation: Low Density Lipoprotein Cholesterol, Value: 139.3 Observation: Cholesterol in HDL [Mass/volume] in Serum or Plasma, Value: 59.78 Observation: Leukocytes [#/volume] in Blood by Automated count, Value: 8.696 Observation: Erythrocytes [#/volume] in Blood by Automated count, Value: 5.332 Observation: Hemoglobin [Mass/volume] in Blood, Value: 14.449 Observation: Hematocrit [Volume Fraction] of Blood by Automated count, Value: 49.205 Observation: MCV [Entitic volume] by Automated count, Value: 93.265 Observation: MCH [Entitic mass] by Automated count, Value: 29.405 Observation: MCHC [Mass/volume] by Automated count, Value: 35.216 Observation: Erythrocyte distribution width [Entitic volume] by Automated count, Value: 42.886 Observation: Platelets [#/volume] in Blood by Automated count, Value: 207.99 Observation: Platelet distribution width [Entitic volume] in Blood by Automated count, Value: 389.36 Observation: Platelet mean volume [Entitic volume] in Blood by Automated count, Value: 11.532 Observation: Tobacco smoking status, Value: Unknown value Observation: Physical findings of Prostate, Value: Unknown value Observation: Prostate specific Ag [Mass/volume] in Serum or Plasma, Value: 6.4973 Medication: verapamil hydrochloride 80 MG Oral Tablet, Dosage: Unknown dosage Medication: Digoxin 0.125 MG Oral Tablet, Dosage: Unknown dosage Medication: Warfarin Sodium 5 MG Oral Tablet, Dosage: Unknown dosage Condition: Suspected prostate cancer (situation), Onset: 2024-06-29T17:48:05+00:00 Observation: US Guidance for biopsy of Prostate, Value: Unknown value Condition: Neoplasm of prostate (disorder), Onset: 2024-06-29T18:18:05+00:00 Condition: Carcinoma in situ of prostate (disorder), Onset: 2024-06-29T18:18:05+00:00 Condition: Full-time employment (finding), Onset: 2024-06-29T18:44:43+00:00 Condition: Limited social contact (finding), Onset: 2024-06-29T18:44:43+00:00 Condition: Stress (finding), Onset: 2024-06-29T18:44:43+00:00 Condition: Gingivitis (disorder), Onset: 2024-06-29T19:56:05+00:00 Observation: Glucose [Mass/volume] in Blood, Value: 81.57 Observation: Urea nitrogen [Mass/volume] in Blood, Value: 11.21 Observation: Creatinine [Mass/volume] in Blood, Value: 3.0681 Observation: Calcium [Mass/volume] in Blood, Value: 9.78 Observation: Sodium [Moles/volume] in Blood, Value: 138.77 Observation: Potassium [Moles/volume] in Blood, Value: 3.86 Observation: Chloride [Moles/volume] in Blood, Value: 101.69 Observation: Carbon dioxide, total [Moles/volume] in Blood, Value: 25.92 Observation: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD), Value: 10.091 Observation: Protein [Mass/volume] in Serum or Plasma, Value: 7.631 Observation: Albumin [Mass/volume] in Serum or Plasma, Value: 3.5069 Observation: Globulin [Mass/volume] in Serum by calculation, Value: 3.2647 Observation: Bilirubin.total [Mass/volume] in Serum or Plasma, Value: 0.33111 Observation: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma, Value: 23.796 Observation: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma, Value: 47.338 Observation: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma, Value: 10.53 Observation: Appearance of Urine, Value: Unknown value Observation: Odor of Urine, Value: Unknown value Observation: Clarity of Urine, Value: Unknown value Observation: Color of Urine, Value: Unknown value Observation: Glucose [Mass/volume] in Urine by Test strip, Value: 2.1372 Observation: Glucose [Presence] in Urine by Test strip, Value: Unknown value Observation: Bilirubin.total [Mass/volume] in Urine by Test strip, Value: 0.56875 Observation: Bilirubin.total [Presence] in Urine by Test strip, Value: Unknown value Observation: Ketones [Mass/volume] in Urine by Test strip, Value: 4.5749 Observation: Ketones [Presence] in Urine by Test strip, Value: Unknown value Observation: Specific gravity of Urine by Test strip, Value: 1.0053 Observation: pH of Urine by Test strip, Value: 6.0879 Observation: Protein [Mass/volume] in Urine by Test strip, Value: 426.17 Observation: Protein [Presence] in Urine by Test strip, Value: Unknown value Observation: Nitrite [Presence] in Urine by Test strip, Value: Unknown value Observation: Hemoglobin [Presence] in Urine by Test strip, Value: Unknown value Observation: Leukocyte esterase [Presence] in Urine by Test strip, Value: Unknown value Observation: Leukocytes [#/volume] in Blood by Automated count, Value: 3.39 Observation: Erythrocytes [#/volume] in Blood by Automated count, Value: 4.4727 Observation: Hemoglobin [Mass/volume] in Blood, Value: 17.183 Observation: Hematocrit [Volume Fraction] of Blood by Automated count, Value: 41.675 Observation: MCV [Entitic volume] by Automated count, Value: 89.026 Observation: MCH [Entitic mass] by Automated count, Value: 28.011 Observation: MCHC [Mass/volume] by Automated count, Value: 33.797 Observation: Erythrocyte distribution width [Entitic volume] by Automated count, Value: 44.112 Observation: Platelets [#/volume] in Blood by Automated count, Value: 203.46 Observation: Platelet distribution width [Entitic volume] in Blood by Automated count, Value: 423.66 Observation: Platelet mean volume [Entitic volume] in Blood by Automated count, Value: 10.512 Observation: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE], Value: Unknown value Observation: Total score [HARK], Value: 0 Observation: Total score [DAST-10], Value: 1 Medication: Unknown medication, Dosage: Unknown dosage Medication: Unknown medication, Dosage: Unknown dosage Condition: Acute viral pharyngitis (disorder), Onset: 2024-08-08T12:44:47+00:00 Observation: Body temperature, Value: 37.497 Observation: Glucose [Mass/volume] in Blood, Value: 87.76 Observation: Urea nitrogen [Mass/volume] in Blood, Value: 15.74 Observation: Creatinine [Mass/volume] in Blood, Value: 2.9271 Observation: Calcium [Mass/volume] in Blood, Value: 9.7 Observation: Sodium [Moles/volume] in Blood, Value: 141.61 Observation: Potassium [Moles/volume] in Blood, Value: 4.53 Observation: Chloride [Moles/volume] in Blood, Value: 101.59 Observation: Carbon dioxide, total [Moles/volume] in Blood, Value: 25.73 Observation: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD), Value: 5.5271 Observation: Protein [Mass/volume] in Serum or Plasma, Value: 6.0215 Observation: Albumin [Mass/volume] in Serum or Plasma, Value: 3.8958 Observation: Globulin [Mass/volume] in Serum by calculation, Value: 3.0673 Observation: Bilirubin.total [Mass/volume] in Serum or Plasma, Value: 0.26656 Observation: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma, Value: 54.069 Observation: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma, Value: 45.545 Observation: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma, Value: 17.989 Observation: Appearance of Urine, Value: Unknown value Observation: Odor of Urine, Value: Unknown value Observation: Clarity of Urine, Value: Unknown value Observation: Color of Urine, Value: Unknown value Observation: Glucose [Mass/volume] in Urine by Test strip, Value: 2.1047 Observation: Glucose [Presence] in Urine by Test strip, Value: Unknown value Observation: Bilirubin.total [Mass/volume] in Urine by Test strip, Value: 1.2743 Observation: Bilirubin.total [Presence] in Urine by Test strip, Value: Unknown value Observation: Ketones [Mass/volume] in Urine by Test strip, Value: 15.875 Observation: Ketones [Presence] in Urine by Test strip, Value: Unknown value Observation: Specific gravity of Urine by Test strip, Value: 1.0367 Observation: pH of Urine by Test strip, Value: 5.127 Observation: Protein [Mass/volume] in Urine by Test strip, Value: 348.02 Observation: Protein [Presence] in Urine by Test strip, Value: Unknown value Observation: Nitrite [Presence] in Urine by Test strip, Value: Unknown value Observation: Hemoglobin [Presence] in Urine by Test strip, Value: Unknown value Observation: Leukocyte esterase [Presence] in Urine by Test strip, Value: Unknown value Observation: Leukocytes [#/volume] in Blood by Automated count, Value: 1.2277 Observation: Erythrocytes [#/volume] in Blood by Automated count, Value: 5.1627 Observation: Hemoglobin [Mass/volume] in Blood, Value: 14.884 Observation: Hematocrit [Volume Fraction] of Blood by Automated count, Value: 46.32 Observation: MCV [Entitic volume] by Automated count, Value: 93.243 Observation: MCH [Entitic mass] by Automated count, Value: 31.566 Observation: MCHC [Mass/volume] by Automated count, Value: 34.969 Observation: Erythrocyte distribution width [Entitic volume] by Automated count, Value: 39.16 Observation: Platelets [#/volume] in Blood by Automated count, Value: 249 Observation: Platelet distribution width [Entitic volume] in Blood by Automated count, Value: 363.67 Observation: Platelet mean volume [Entitic volume] in Blood by Automated count, Value: 12.25 Medication: Unknown medication, Dosage: Unknown dosage Medication: Unknown medication, Dosage: Unknown dosage